For the first time, the agreement specifically addresses agricultural biotechnology to support twenty-first century innovation in agriculture. The text covers all biotechnologies, including new technologies such as gene editing, while the trans-Pacific partnership text covered only traditional rDNA technology. In particular, the United States, Mexico and Canada have agreed on provisions to improve information exchange and trade cooperation in the field of agricultural biotechnology. The Parties agreed to put in place important procedural safeguards for the recognition of new geographical indications, including strong standards of protection against the grant of geographical indications that would prevent producers in the United States from using common names, as well as a mechanism for consultation between the Parties on future geographical indications, in accordance with international agreements. The chapter on technical barriers to trade (TBT) is an important extension of NAFTA. It includes standards, technical rules and conformity assessment procedures (assessment of products to ensure that they meet the requirements) which may affect trade between the Contracting Parties. In order to increase cross-border trade, the United States has entered into an agreement with Mexico and Canada to increase their de minimis shipping value. For the first time in decades, Canada will increase from C$20 ($15.38) to C$40 ($30.77) for taxes. Canada also provides duty-free shipments of up to C$150 ($115.38). Mexico will continue to provide $50 tax-free de minimis and will also offer duty-free shipments worth $117.
Dissemination values up to these levels would occur with a minimum of formal entry procedures, making it easier for more businesses, especially small and medium-sized enterprises, to be part of cross-border trade. Canada will also allow the importer to pay taxes 90 days after entry. In the chapter “Sanitary and Phytosanitary Measures” (SPS), the United States, Mexico and Canada agreed to strengthen disciplines on science-based spS measures, while ensuring that the Parties respect their sovereign right to the protection of human, animal and plant life or health. Provisions include improving transparency in the development and implementation of SPS actions; promoting science-based decision-making; improve certification, regionalization and equivalence processes; conducting system-based audits; improve the transparency of import controls; and cooperate to improve the compatibility of measures. The new agreement would establish a new technical consultation mechanism to resolve issues between the parties. In addition to its work with the WTO, the United States has concluded trade agreements with 20 countries covering a number of issues, ranging from tariffs on goods and agricultural market access to intellectual property and the environment. For the FDA, specific topics are chapters of regulatory agreements such as SPS MEASURES, OET and Good Regulatory Practices – as well as sector chapters on cosmetics, medical devices and medicines, where applicable. The FDA helps develop U.S. negotiating proposals, and the FDA actively participates in business meetings with U.S. trading partners.
On December 10, 2019, a revised USMCA agreement was concluded by the three countries. On January 29, 1, 2020, Deputy Prime Minister and Minister of Intergovernmental Affairs Chrystia Freeland introduced the USMCA C-4 Implementation Act in the House of Commons and passed first reading without a recorded vote. On February 6, the bill was passed in the House of Commons by a vote of 275 to 28 at second reading, with the Bloc Québécois voting against and all other parties, and was referred to the Standing Committee on International Trade.    On February 27, 2020, the committee voted to refer the bill back to the plenary for third reading, without amendment. An April 2019 International Trade Commission analysis of the likely effects of the USMCA estimated that if fully implemented (six years after ratification), the agreement would increase the United States. . . .